Baseline characteristics
. | Mild bleeding phenotype (n = 23) . | Severe bleeding phenotype (n = 10) . | P . |
---|---|---|---|
Age at inclusion, years* | 10 (6-13) | 12 (8-15) | .576 |
Age at diagnosis, years* | 3 (2-9) | 4 (2-12) | .773 |
Sex, male† | 6 (26) | 3 (30) | 1.000 |
Platelet count at day of inclusion, ×109/L* | 74 (53-117) | 58 (14-156) | .805 |
MPV at day of inclusion, fL* | 9.4 (8.6-11.6) | 10.8 (8.4-14.8) | .216 |
Positive indirect PIFT† | 2 (9) | 1 (10) | 1.000 |
Positive indirect MAIPA† | 4 (17) | 2 (20) | 1.000 |
. | Mild bleeding phenotype (n = 23) . | Severe bleeding phenotype (n = 10) . | P . |
---|---|---|---|
Age at inclusion, years* | 10 (6-13) | 12 (8-15) | .576 |
Age at diagnosis, years* | 3 (2-9) | 4 (2-12) | .773 |
Sex, male† | 6 (26) | 3 (30) | 1.000 |
Platelet count at day of inclusion, ×109/L* | 74 (53-117) | 58 (14-156) | .805 |
MPV at day of inclusion, fL* | 9.4 (8.6-11.6) | 10.8 (8.4-14.8) | .216 |
Positive indirect PIFT† | 2 (9) | 1 (10) | 1.000 |
Positive indirect MAIPA† | 4 (17) | 2 (20) | 1.000 |